Classifications

• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
  • A61K35/56—Materials from animals other than mammals
  • A61K35/63—Arthropods
  • A61K35/64—Insects, e.g. bees, wasps or fleas
  • A61K35/644—Beeswax; Propolis; Royal jelly; Honey

Definitions

• the subject of the invention is a process for manufacturing veterinary products - e . g. udder infusion, ointment, emulsion , etc .
• mastitis affects in most case s cows with big milk production which is easy to understand knowing the fact that production of 1 litre of milk requires 300 to 500 litres of blood to flow through the lactiferous gland. The new process is of great importance since mastitis
• the yearly loss in Hungary is estimated to reach HUF 720 to 750 millions at present, the same in the USA amounts to US D 1294 millions which means a yearly loss of USD 150 to 300 per c ow, caused by mastitits.
• the yearly loss caused by this disease in European countries is estimated as follows :
• Garget generally decreases the total milk production by 11 % in each country. The damages are listed below:
• gargets are highly influenced by the prevailing conditions of animal keeping, feeding and hygiene and also by the breeder of animals himself. This means that the appearance and severity of garget varies a lot with diaries and individuals - depending on the conditions mentioned.
• the pathogens causing infection /bacteria, fungi, viruses, etc. / reach the lacteal tracks of the udder in most cases in a galactogen way and the parenchyme of the udder resp. bringing on disease of varying severity, depending on their patho genetics and resistance of the organism or udder respectively.
• Local medical treatment is generally applied in case of disease manifesting itself by clinical symptoms .
• the invention has the aim to provide a process to produce veterinary preparations eliminating the above mentioned disadvantage , for treatment of mastitis and the product thus obtained.
• udder infusion of 2 decilitres meets several litres of milk in the milk pelvis of both the milkers and non-milkers
• the received system containing complex emulsifier is to be introduced from the disposable plastic appliance into the diseased uddersection where it meets the milk and becomes activated.
• the main point of the invention-based preparation is consequently that its active ingredient is soft propolis of 0,5 -10 v/v %
• Paraffinum liquidum 431 0 g
• the total weight of the components used in both cases 750,0 g .
• Example 3 Standard propolis concentrate /soft propolis / 15 g
• Soft propolis 0,5-10 /optimally 6/ v/v % was mixed with an indifferent solvent of hydrophilous character /propyleneglycol - polioxaeten 400/ , for practical purposes with propylenglycol .
• the active ingredient content is bactericide , viricide and fungicide on a quite wide scale
• the preparations have a significant antiphlogistic, local anaesthetic, epidermidalizationing and an analgetic effect;
• the milk produced from the treated udder has no more germicidal substance content after 6 hours, thus the value of milk does not drop.

Landscapes

• Health & Medical Sciences (AREA)
• Life Sciences & Earth Sciences (AREA)
• Insects & Arthropods (AREA)
• Epidemiology (AREA)
• General Health & Medical Sciences (AREA)
• Chemical & Material Sciences (AREA)
• Medicinal Chemistry (AREA)
• Pharmacology & Pharmacy (AREA)
• Animal Husbandry (AREA)
• Animal Behavior & Ethology (AREA)
• Zoology (AREA)
• Public Health (AREA)
• Veterinary Medicine (AREA)
• Medicines Containing Material From Animals Or Micro-Organisms (AREA)
• Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
• Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
• Medicinal Preparation (AREA)

Applications Claiming Priority (2)

Publications (1)

Family

ID=10950120

Family Applications (1)

Country Status (11)

Families Citing this family (5)

Family Cites Families (7)

• 1988
  • 1988-02-08 HU HU88551A patent/HU198843B/hu not_active IP Right Cessation
• 1989
  • 1989-02-07 IL IL89204A patent/IL89204A0/xx unknown
  • 1989-02-08 DD DD89325628A patent/DD280037A5/de not_active IP Right Cessation
  • 1989-02-08 AU AU30516/89A patent/AU629201B2/en not_active Ceased
  • 1989-02-08 WO PCT/HU1989/000004 patent/WO1989006955A1/en not_active Application Discontinuation
  • 1989-02-08 EP EP89902276A patent/EP0356479A1/en not_active Withdrawn
  • 1989-02-08 ES ES8900791A patent/ES2012675A6/es not_active Expired - Fee Related
  • 1989-02-09 GR GR890100080A patent/GR1000497B/el unknown
  • 1989-02-13 NZ NZ227957A patent/NZ227957A/en unknown
  • 1989-10-04 DK DK489989A patent/DK489989A/da not_active Application Discontinuation
  • 1989-10-06 FI FI894756A patent/FI894756A0/fi not_active IP Right Cessation

Non-Patent Citations (1)

Also Published As

Similar Documents

Legal Events